Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aiyi (TS-1) in advanced metastatic breast cancer
NCT01492543Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur + gimeracil + oteracil potassium in breast cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
tegafur + gimeracil + oteracil potassium
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01492543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01492543.